|
Angiodynamics Inc (NASDAQ: ANGO) |
|
Angiodynamics Inc
ANGO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Angiodynamics Inc 's sales fell
by -4.01 % in III. Quarter 2025 from the same quarter a year ago.
Ranking at No. 26
Medical Equipment & Supplies industry recorded
deterioration of revenues by -4.01 %
Angiodynamics Inc net loss decreased from $-188 millions, to $-4 millions in III. Quarter 2025,
• More on ANGO's Growth
|
|
Angiodynamics Inc realized a net loss in trailing twelve months.
Angiodynamics Inc realized cash reduction of $ -0.82 per share in trailing twelve-month period. Medical Equipment & Supplies industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.38.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.92.
• More on ANGO's Valuation
|
|
|
|
|
Angiodynamics Inc realized net loss in trailing twelve months.
Angiodynamics Inc realized cash outflow of $ -0.82per share in trailing twelve-month period. Medical Equipment & Supplies industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1.38.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.92.
Angiodynamics Inc Price to Book Ratio is at 2.1 higher than Industry Avg. of -446.56, and higher than S&P 500 Avg. of 0.01
• More on ANGO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com